(Q52901217)

9 May 2018

title

Expression of the stem cell markers nestin and CD133 on circulating melanoma cells. (English)

1 reference

9 May 2018

author

Sebastian Ochsenreither

4

1 reference

9 May 2018

author name string

Alberto Fusi

1

1 reference

9 May 2018

Uta Reichelt

2

1 reference

9 May 2018

Antonia Busse

3

1 reference

9 May 2018

Anika Rietz

5

1 reference

9 May 2018

Markus Maisel

6

1 reference

9 May 2018

Ulrich Keilholz

7

1 reference

9 May 2018

language of work or name

English

0 references

publication date

30 September 2010

1 reference

9 May 2018

Journal of Investigative Dermatology

published in

1 reference

9 May 2018

volume

131

1 reference

9 May 2018

issue

2

1 reference

9 May 2018

page(s)

487-494

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1038/jid.2010.285

exact match

0 references

cites work

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Melanoma, a tumor based on a mutant stem cell?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

CD133+CD44+ population efficiently enriches colon cancer initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Tumor growth need not be driven by rare cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells"

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Increased expression of stem cell markers in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Efficient tumour formation by single human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Identification of cells initiating human melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Cancer stem cells in nervous system tumors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.285

7 January 2021

Identifiers

DOI

10.1038/JID.2010.285

1 reference

9 May 2018

PubMed ID

20882037

1 reference

9 May 2018